Endo International sells its men's health and prostate business to Boston Scientific. The deal is worth $1.65 billion, which is expected to close in the third quarter of this year.
Endo International sells its men's health and prostate business to Boston Scientific. The deal is worth $1.65 billion, which is expected to close in the third quarter of this year.